코오롱티슈진 TG-C, 무릎에서 척추까지 적응증 확대 나선다

Apr 24, 2023

코오롱티슈진, 세계적인 골관절염학회에서 TG-C의 안전성과 유효성에 힘 실었다.

Apr 3, 2023

Kolon TissueGene To Expand Indications For TG-C

Dec 3, 2021

Kolon Tissuegene Announces Plans To Resume US Phase III Clinical Trial For TG-C

Apr 13, 2020

Kolon TissueGene Doses First Patient in US Phase III Clinical Trial

Nov 21, 2018

Kolon TissueGene to Expand License Agreement for INVOSSA™ with Kolon Life Science

Jun 26, 2018

TissueGene Announces Company Name Change To Kolon TissueGene, Inc.

Mar 16, 2018

TissueGene To Present Clinical Trial Data For Its Cell And Gene Therapy For Osteoarthritis At Cell Therapy World Asia 2017

Sep 15, 2017

TissueGene Recognized During Maryland Commerce, State Departments' Week-Long Trade Mission To South Korea

Sep 11, 2017

TissueGene Awarded $750,000 Maryland Stem Cell Grant for Invossa™ Clinical Study

Jun 30, 2017